Leukotriene B<sub>4</sub>antagonism ameliorates experimental lymphedema
Wen Tian(VA Palo Alto Health Care System), Mark R. Nicolls(VA Palo Alto Health Care System), Jan Kitajewski(University of Illinois Chicago), Zhanna Nepiyushchikh(Georgia Institute of Technology), Xinguo Jiang(VA Palo Alto Health Care System), Adrian Begaye(Stanford University), Matthew T. Cribb(Georgia Institute of Technology), Roham T. Zamanian(Verizon (United States)), J. Brandon Dixon(Georgia Institute of Technology), Gundeep Dhillon(Stanford University), Stanley G. Rockson(Stanford University), Jeanna Kim(Fred Hutch Cancer Center), Eric Shuffle(VA Palo Alto Health Care System), Allen B. Tu(VA Palo Alto Health Care System), Marc Peters‐Golden(Michigan Medicine), Norbert F. Voelkel(Amsterdam University Medical Centers), Abdullah H. Feroze(Children's National)
Cited by 169
Related Papers
Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL
|CHEST Journal|2010|432
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
|Science Translational Medicine|2017|427
Molecular pathogenesis of emphysema
|Journal of Clinical Investigation|2008|259
Inflammatory Manifestations of Experimental Lymphatic Insufficiency
|PLoS Medicine|2006|222
Single-cell CUT&Tag analysis of chromatin modifications in differentiation and tumor progression
|Nature Biotechnology|2021|210